A Comprehensive Analysis of Pattern Recognition Receptors in Normal and Inflamed Human Epidermis: Upregulation of Dectin-1 in Psoriasis  by de Koning, Heleen D. et al.
A Comprehensive Analysis of Pattern Recognition
Receptors in Normal and Inflamed Human Epidermis:
Upregulation of Dectin-1 in Psoriasis
Heleen D. de Koning1,2,3,4, Diana Rodijk-Olthuis1, Ivonne M.J.J. van Vlijmen-Willems1, Leo A.B. Joosten2,3,4,
Mihai G. Netea2,3,4, Joost Schalkwijk1,2,3 and Patrick L.J.M. Zeeuwen1,2,3
Human epidermis plays an important role in host defense by acting as a physical barrier and signaling interface
between the environment and the immune system. Pattern recognition receptors (PRRs) are crucial to maintain
homeostasis and provide protection during infection, but are also causally involved in monogenic auto-
inflammatory diseases. This study aimed to investigate the epidermal expression of PRRs and several associated
host defense molecules in healthy human skin, psoriasis, and atopic dermatitis (AD). Using microarray analysis
and real-time quantitative PCR, we found that many of these genes are transcribed in normal human epidermis.
Only a few genes were differentially induced in psoriasis (CLEC7A (dectin-1), Toll-like receptor (TLR) 4,
and mannose receptor C type 1 (MRC1)) or AD (MRC1, IL1RN, and IL1b) compared with normal epidermis.
A remarkably high expression of dectin-1 mRNA was observed in psoriatic epidermis and this was corroborated
by immunohistochemistry. In cultured primary human keratinocytes, dectin-1 expression was induced by IFN-g,
IFN-a, and Th17 cytokines. Keratinocytes were unresponsive, however, to dectin-1 ligands such as b-glucan or
heat-killed Candida albicans, nor did we observe synergy with TLR2/TLR5 ligands. In conclusion, upregulation of
dectin-1 in psoriatic lesions seems to be under control of psoriasis-associated cytokines. Its role in the biology
of skin inflammation and infection remains to be explored.
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INTRODUCTION
Psoriasis and atopic dermatitis (AD) are common chronic
inflammatory skin conditions with distinct transcriptional
programs in keratinocytes (Zeeuwen et al., 2008). In
psoriasis, antimicrobial proteins are strongly upregulated, in
contrast to AD, which was suggested to account for the
increased susceptibility to skin infections in AD (Ong et al.,
2002; Nomura et al., 2003a; de Jongh et al., 2005; Zeeuwen
et al., 2008; Harder et al., 2010). This raises the question,
which signaling cascades precede these distinct expression
profiles of innate response genes in psoriasis and AD. At the
very frontline of innate immune surveillance are the pattern
recognition receptors (PRRs) that in humans comprise four
main groups, Toll-like receptors (TLRs), nucleotide-binding
oligomerization domain (NOD)-like receptors (NLRs),
RIG-like helicase receptors (RLRs), and C-type lectin recep-
tors (Kawai and Akira, 2009). Together, TLRs can sense a
wide array of bacterial, viral, fungal, and protozoan ligands.
The endosomal TLRs 3, 7, 8 and 9 mainly recognize viral
nucleic acids, whereas the remaining TLRs, located on the
plasma membrane, harbor mostly bacterial specificity (Barton
and Kagan, 2009). NLRs mainly recognize bacterial compo-
nents, but NLR family pyrin domain containing 3 (NLRP3)
recognizes numerous stimuli. Viral single- (ss) and double-
stranded (ds) RNA are sensed by the RLRs, but dsRNA also
by TLR3. C-type lectin domain family 7 member A (CLEC7A),
or dectin-1, is the best-known C-type lectin receptor and
recognizes the fungal cell wall component b-glucan (Taylor
et al., 2007; Reid et al., 2009). PRR activation initiates a
specific cascade that eventually leads to a tailored immune
response against the recognized agent, as was also estab-
lished in keratinocytes (Miller and Modlin, 2007). Cytokines
and type I IFNs are the downstream signaling molecules that
mediate leukocyte chemotaxis, secretion of antimicrobial
proteins, and vascular effects. Recent findings show that
activation of innate PRRs shapes adaptive immune responses,
e.g., by attracting specific kinds of T helper cells (Palm and
Medzhitov, 2009).
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Reports on PRR mRNA and protein expression in human
skin are scarce and have mainly focused on TLRs (Hayashi
et al., 2001; Kawai et al., 2002; Song et al., 2002;
Baker et al., 2003; Mempel et al., 2003; Kollisch et al.,
2005; Miller et al., 2005; Begon et al., 2007; Lebre et al.,
2007; Kobayashi et al., 2009). TLR1-3, 5 and 9 are present in
normal human skin in vivo and responsive to ligands in vitro
in primary human keratinocytes. Reports on TLR4 in skin are
conflicting: some did, others did not find in vivo expression
or response after lipopolysaccharide stimulation. Epidermal
expression of TLR6 and TLR10 was often detected, whereas
TLR7 and TLR8 expression and function were absent in most
studies. NOD1 and NOD2 were functionally expressed
(Harder and Nunez, 2009; Kobayashi et al., 2009), as were
dsRNA receptors (Kalali et al., 2008; Prens et al., 2008).
Dectin-1 was upregulated by Mycobacterium ulcerans and
mediated its internalization in human keratinocytes (Lee
et al., 2009). In another in vitro study on dectin-1 in keratino-
cytes, data were inconsistent (Kobayashi et al., 2009).
The downside of the extensive immune surveillance
properties of PRRs is that several autoinflammatory diseases
are related directly or indirectly to malfunctioning PRRs
(Neven et al., 2008; Mogensen, 2009). Keeping in mind the
distinct expression profiles of cytokines and effector mole-
cules in psoriasis and AD (Nomura et al., 2003a; de Jongh
et al., 2005), some PRRs might have a pathophysiological
role in these inflammatory disorders. In psoriasis, stronger
immunohistochemical (IHC) staining of TLR2 was found
compared with normal skin (Begon et al., 2007) and TLR
expression patterns seemed to differ (Baker et al., 2003). A
more diffuse epidermal expression of TLR5 and TLR9 was
found in psoriasis, and these TLRs seemed to be upregulated
and functionally potentiated by transforming growth factor-a
(Miller et al., 2005).
In this study, we performed a comprehensive real-time
quantitative PCR (qPCR) analysis on PRR expression and we
provide protein data of selected molecules, while comparing
expression in normal skin, psoriatic plaques, and AD lesions.
Dectin-1 was highly upregulated in psoriatic epidermis.
Expression and functionality of dectin-1 were studied
in vitro by engagement of its natural ligand b-glucan and
cytokine stimulation of primary human keratinocytes.
RESULTS
mRNA expression of innate immunity genes
Our previous microarray analyses and qPCR validation
studies revealed significant epidermal expression of several
PRRs and related signaling molecules (Supplementary Table
S1 online) (de Jongh et al., 2005; Kamsteeg et al., 2009). To
further analyze PRR expression in normal and inflamed skin,
we designed and validated qPCR assays for multiple innate
immunity signaling molecules (Table 1).
We observed large differences in basal expression levels.
RLRs, TLR2, and TLR3 show higher expression levels
compared with other PRRs. Only a limited number of
signaling molecules showed differential expression between
normal and inflamed skin. Dectin-1 mRNA levels were
induced the most in psoriatic epidermis, also compared with
uninvolved skin of psoriatic patients. TLR4, TLR10, and
mannose receptor C type 1 (MRC1) were significantly
induced in psoriasis, although the expression levels were
low (Figure 1 and Table 1). In AD skin, NOD2, MRC1, TLR10,
pyrin domain and caspase recruitment domain-containing
protein (PYCARD), IL-1 receptor antagonist (IL1RN, or IL-1RA)
and IL-1b were significantly induced. When comparing AD
with psoriasis, NLRP3, PYCARD, IL1RN, IL-1a, and IL-1b were
expressed at significantly higher levels in AD, and CLEC2B,
CLEC7A, and ICEBERG in psoriasis.
Protein expression of innate immunity genes
To confirm our qPCR results, we analyzed protein expression
by means of IHC staining of skin sections of normal skin,
psoriatic plaques, and AD lesions (Figure 2). We selected four
proteins that were not previously stained in skin: one C-type
lectin receptor (dectin-1), one RLR (DEAD (Asp-Glu-Ala-Asp)
box polypeptide 58 (DDX58), or melanoma differentiation-
associated gene-5), one NLR (NLRP3), and the caspase-1
inhibitor (ICEBERG). Dectin-1 and NLRP3 were of particular
interest in view of their relatively high transcription levels
in psoriasis and AD, respectively. Indeed, mRNA data of
dectin-1 were confirmed, because strong membrane staining
was observed in psoriasis and intermediate staining in AD
compared with normal skin (Figure 2). Scattered dectin-1-
positive stained Langerhans cells were occasionally
observed, although the strong keratinocyte staining for
dectin-1 makes them difficult to distinguish at first sight.
Immunofluorescence double staining showed that our dectin-1
antibody positively stained keratinocyte membranes as well as
Langerhans cells that are present in the psoriatic epidermis
(Supplementary Figure S1 online). NLRP3 protein levels were
extremely low in skin, whereas a strong staining was found in
the positive control tissue esophagus (not shown). Protein expres-
sion of the cytoplasmic proteins ICEBERG and melanoma
differentiation-associated gene-5 was similar in the three different
conditions (Figure 2).
mRNA expression of dectin-1 in human tissues
As dectin-1 stood out as a robustly upregulated PRR in
psoriatic epidermis both at the mRNA and protein level, we
decided to analyze this receptor in more detail. To compare
the observed high expression in lesional psoriatic epidermis
with other tissues, we performed qPCR analysis of dectin-1 in
a large panel of human tissues, including various epithelia
(Figure 3). Relatively low dectin-1 mRNA expression levels,
comparable to those in normal epidermis, were found in
gastrointestinal and genitourinary tissues. Compared with
normal skin, more than 10-fold higher expression rates were
observed in gingiva, trachea, mammary gland, aorta, and foot
sole, whereas the highest transcription levels were found
in tissues rich in immune cells: tonsil, spleen, lung, and
especially peripheral blood mononuclear cells.
Dectin-1 expression in cultured keratinocytes is induced by
IFNs and Th17 cytokines
Next, we set out to study dectin-1 expression and function
in vitro in previously validated epidermal model systems
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Table 1. qPCR data on pattern recognition receptors and signaling molecules in human epidermis
HUGO mRNA in vivo P-value
1 Ratio DCt
symbol Synonym DCt
2 NS3 DCt PS
4 DCt AD
5 PS/NS AD/NS PS/AD PS/NS AD/NS PS/AD
TLRs
TLR1 14.0 13.2 13.2 0.746 0.975 1.000 2.1 1.9 1.1
TLR2 9.3 7.5 7.8 0.368 0.767 1.000 3.4 2.8 1.2
TLR3 9.4 9.0 9.6 1.000 1.000 0.632 1.4 0.9 1.5
TLR4 21.7 16.5 17.6 0.049 0.118 1.000 16.5 13.9 1.2
TLR5 12.0 11.6 11.2 0.558 0.356 1.000 1.6 1.7 0.9
TLR6 12.2 11.5 11.5 1.000 1.000 1.000 1.8 1.8 1.0
TLR7 18.5 16.2 17.6 0.228 1.000 0.111 5.2 1.8 2.8
TLR8 17.0 14.0 13.8 0.176 0.142 1.000 8.6 9.7 0.9
TLR9 14.6 14.1 13.3 0.185 0.057 0.596 0.7 1.1 0.7
TLR10 17.0 15.0 15.7 0.014 0.044 0.859 3.7 1.8 2.0
CLRs
CLEC2B CLECSF2 4.9 4.0 5.9 1.000 0.649 0.027 1.9 0.5 3.6
CLEC7A Dectin-1 10.9 7.0 8.5 0.002 0.050 0.017 17.3 5.9 2.9
NLRs
NLRP1 NALP1 10.1 11.1 10.5 1.000 0.911 0.605 0.5 0.7 0.7
NLRP2 NALP2 10.3 10.5 7.6 1.000 0.847 0.070 1.4 6.6 0.2
NLRP3 NALP3/CIAS 20.7 16.0 14.2 1.000 0.090 0.004 7.4 25.4 0.3
NOD1 CARD4 11.6 12.7 12.1 1.000 1.000 0.440 0.5 0.6 0.7
NOD2 CARD15 11.3 10.3 9.7 0.059 0.007 0.091 1.9 3.0 0.6
NLRC4 IPAF/CARD12 18.9 16.7 16.1 0.177 0.031 0.215 3.0 4.3 0.7
CARD8 15.5 14.4 14.4 1.000 1.000 1.000 2.1 2.0 1.0
RLRs
DDX58 RIG-I 7.5 6.1 7.4 0.646 1.000 0.130 2.9 1.1 2.8
IFIH1 MDA5 8.7 7.5 8.0 1.000 1.000 1.000 2.5 1.5 1.7
DHX58 LGP2 12.0 12.0 11.0 1.000 1.000 0.651 1.6 2.0 0.8
Diverse
MRC1 15.2 11.4 11.5 o0.001 o0.001 1.000 10.0 10.1 1.0
CHIT3L1 5.5 5.0 5.7 0.887 1.000 0.303 1.4 0.9 1.6
PKR 11.6 9.6 9.0 0.526 0.360 1.000 5.3 6.0 0.9
P2RX7 8.8 9.9 8.2 1.000 0.142 0.114 0.3 1.5 0.2
CARD9 14.0 15.3 15.9 0.070 0.375 1.000 0.3 0.5 0.6
SYK 8.0 8.1 7.4 1.000 0.255 0.006 0.8 1.4 0.6
RAF1 6.0 6.8 6.0 0.017 1.000 0.007 0.5 1.0 0.5
RIPK2 RIP2 6.6 7.5 6.4 1.000 1.000 0.116 0.6 1.1 0.5
PYCARD ASC 6.9 7.0 6.0 0.059 0.005 0.043 0.9 1.7 0.5
ICEBERG Casp1 inhibitor 7.6 6.3 7.9 1.000 1.000 0.022 2.4 0.9 2.7
CASP1 ICE 6.7 5.4 6.2 0.137 0.926 0.168 2.5 1.4 1.8
IL1RN IL-1RA 10.2 8.7 6.6 0.110 0.003 0.004 2.9 13.5 0.2
Table 1 continued on the following page
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Table 1. Continued
HUGO mRNA in vivo P-value
1 Ratio DCt
symbol Synonym DCt
2 NS3 DCt PS
4 DCt AD
5 PS/NS AD/NS PS/AD PS/NS AD/NS PS/AD
IL1A IL-1a 14.7 14.9 11.5 1.000 0.225 0.004 0.9 15.9 0.1
IL1B IL-1b 14.9 12.7 10.4 0.180 0.003 0.002 3.6 40.8 0.1
IL18 IL-18 4.8 4.8 4.5 1.000 0.575 0.601 1.0 1.1 0.9
Abbreviations: AD, atopic dermatitis; ANOVA, analysis of variance; CLR, C-type lectin receptor; NLR, nucleotide-binding oligomerization domain (NOD)-
like receptor; NS, normal skin; PS, psoriasis; qPCR, real-time quantitative PCR; RLR, RIG-like helicase receptor; TLR, Toll-like receptor.
1P-values of ANOVA and Bonferroni post hoc test. Bold: P-value o0.05. Shaded: upregulated more than 10 times.
2DCt: DPCR cycle time.
3mRNA expression data from epidermal cells of normal skin (N=5).
4mRNA expression data from epidermal cells of psoriatic plaques (N=9).
5mRNA expression data from epidermal cells of atopic dermatitis lesions (N=6). All data are corrected for primer efficiency.
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Figure 1. Relative mRNA expression levels of PRRs and related signaling molecules in human epidermis. (a) TLRs; (b) NLRs, CLRs, and RLRs; and (c) other PRR-
related signaling molecules. mRNA expression data from human epidermal sheets of normal skin (N¼ 5), psoriatic plaques (N¼ 9), and AD lesions (N¼ 6). TLR4 in
normal skin was used as a reference value (relative quantity of 1) in calculating the relative quantities of all gene expression levels. It is to be noted that the relative
quantity is presented in a log10 scale. Bars indicate mean±SEM. *P-valueo0.05 compared with normal skin. AD, atopic dermatitis; NS, normal skin; PS, psoriasis.
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(van Ruissen et al., 1996; Zeeuwen et al., 2008). In
differentiated keratinocyte cultures that show a normal skin
phenotype, dectin-1 mRNA expression levels were low. To
induce dectin-1 expression for subsequent ligand stimulation,
we incubated keratinocytes with several cytokines including
IFN-a or IFN-g, Th2 cytokines (IL-4 and IL-13), Th17
cytokines (IL-17 and IL-22), and a proinflammatory cytokine
mixture (IL-1a, IL-6, and tumor necrosis factor-a).
After 24 hours, dectin-1 mRNA levels increased the most
(12-fold) after stimulation with IFN-g (Figure 4), which
was dose dependent (not shown). Interestingly, the Th17
mixture induced dectin-1 transcription 10-fold, but this effect
appeared only after 48 hours. Dectin-1 was induced 5-fold by
IFN-a and 6-fold by the proinflammatory mixture after
48 hours. Stimulation with Th2 cytokines (Figure 4) or fetal
calf serum (not shown), a known inducer of stress signaling in
keratinocytes, did not affect dectin-1 expression.
Stimulation of keratinocytes by dectin-1 ligands
To obtain higher a priori dectin-1 levels, we preincubated
primary human keratinocytes from four different donors for
24 hours with IFN-g before stimulation with the dectin-1
ligands b-glucan (50 mgml–1) or heat-killed Candida
(5*106ml–1). As dectin-1 reinforces TLR2 and TLR5 responses
in monocytes and macrophages (Kikkert et al., 2007;
Ferwerda et al., 2009), co-stimulation of their respective
ligands Pam3Cys (10 mgml–1) and flagellin (50 mgml–1) with
b-glucan or heat-killed Candida was also performed. Ligand
addition hardly influenced mRNA levels of dectin-1 itself (not
shown). As a functional readout for dectin-1-mediated
stimulation, we examined the expression of proinflammatory
cytokines and antimicrobial proteins with known anti-fungal
activity (hBD-2, secretory leukoprotease inhibitor, elafin, and
S100A8). b-Glucan caused significant, moderate upregula-
tion of IL-23 mRNA after 48 hours, but neither b-glucan nor
heat-killed Candida had significant effect on the expression of
the other cytokines or antimicrobial proteins. In contrast,
flagellin induced IL-23, IL-8, and IL-1b mRNA, especially
after 24 hours. Flagellin strongly induced DEFB4 and weakly
PI3 and S100A8, most notably after 48 hours. Pam3Cys
induced IL-23 and IL-8 transcription to a small extent at
this concentration. After 48 hours, addition of b-glucan to
flagellin or Pam3Cys significantly induced IL-23 and IL-8
mRNA levels, respectively. Such synergy was not observed
after the addition of heat-killed Candida (Figure 5a and
Supplementary Figure S2A online; 48- and 24-hour data
respectively).
ELISAs were performed for IL-1b, IL-6, IL-8, IL-23, and
hBD-2 in supernatants. Although IL-23 mRNA was clearly
present, no IL-23 protein could be detected in the super-
natants and only very low secreted IL-1b levels. The
transcriptional induction of IL-6, IL-8, and hBD-2 by flagellin
or Pam3Cys was reflected by strongly increased protein levels
(Figure 5b and Supplementary Figure S2B online). The small
synergistic effects of b-glucan with Pam3Cys or flagellin as
determined by qPCR were not observed at the protein level.
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Figure 2. Protein expression of dectin-1, melanoma differentiation-associated gene-5 (MDA5), and ICEBERG in human epidermis. Immunohistochemical
staining of normal skin, psoriatic plaques, and atopic dermatitis lesions. Each picture is representative of data from three different individuals. Bar¼100 mm.
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DISCUSSION
In this study, we show that many PRRs and other host defense
genes are expressed in human epidermis, albeit to a different
extent. RLRs, TLR2, and TLR3 were more abundant than other
PRRs. Interestingly, PRR and signaling gene expression
profiles in epidermal sheets of psoriasis and AD were rather
similar to those in healthy skin, in contrast to effector
molecule expression levels (de Jongh et al., 2005; Zeeuwen
et al., 2008). However, MRC1 was upregulated in both
disorders and dectin-1 was the most notable exception with
higher expression levels in psoriasis.
The reason for the relatively high constitutive expression
levels of TLR2, TLR3, CLEC2B, DDX58, and IFIH1 in skin
remains elusive. Possibly, their respective specificities are
vital to the immunological epidermal barrier function,
whereas other PRRs can be upregulated in response to
specific microbes. It is remarkable that viral dsRNA sensors
(TLR3, DDX58, and IFIH1) are all constitutively strongly
expressed in epidermis, unlike endosomal ssRNA receptors
TLR7 and TLR8 and DNA receptor TLR9. Interestingly,
pathophysiological roles of TLR7 and TLR9, but not TLR3,
have been implicated in several autoimmune diseases, such
as systemic lupus erythematodes (Berland et al., 2006;
Christensen and Shlomchik, 2007). Still, it was previously
unclear why keratinocytes are highly sensitive to TLR3
ligands, as viruses, the major source of dsRNA, are not
among the most prevalent causes of skin infection. Recently,
TLR3 was shown to be crucial in the initiation of inflamma-
tion in wound healing and TLR2 in dampening of the TLR3-
mediated inflammatory response (Lai et al., 2009). Indeed,
TLR3 has been implicated as a mechanism for detection of
cell death by sensing self-RNA (Kariko et al., 2004; Cavassani
et al., 2008).
Previous studies reported high epidermal expression levels
of effector molecules in psoriasis and lower ones in AD,
which raised the question whether these differences resulted
from distinct PRR or signaling gene expression profiles (Ong
et al., 2002; Nomura et al., 2003b; de Jongh et al., 2005;
Howell, 2007). In this study, we show that epidermal PRR
mRNA expression levels in healthy skin and psoriatic and AD
skin lesions are rather similar, apart from a few exceptions.
MRC1, which binds high-mannose surface structures of
viruses, bacteria, and fungi, was significantly and equally
upregulated in psoriasis and AD, indicating that this might be
a general response of inflamed skin to sense pathogens in the
context of compromised skin barrier function. We recently
reported that MRC1 is the sole receptor able of directly
inducing IL-17 production in human peripheral blood
mononuclear cells, and that this pathway is amplified by
dectin-1/TLR2 signaling (van de Veerdonk et al., 2009). TLR4
is borderline-significantly upregulated in psoriasis, but its
functional relevance is questionable seeing its very low
expression. NLRP3 expression was strongly induced in AD,
but only low mRNA levels and no protein expression could
be detected while esophageal epithelium stained strongly.
Indeed, strong IHC staining of NLRP3 was previously found
in non-keratinizing squamous epithelium (oral cavity, eso-
phagus, and ectocervix) and transitional epithelium (bladder),
whereas it was absent in skin (Kummer et al., 2007). The
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Figure 3. Relative mRNA expression levels of CLEC7A (dectin-1) in a panel
of human tissues. Equal amounts from each tissue were analyzed by
qPCR. CLEC7A expression levels in normal epidermis, psoriasis, and atopic
dermatitis were taken from Figure 1. Normal epidermis was used as a
reference value (relative quantity of 1) in calculating the relative quantities
of all gene expression levels. PBMCs, peripheral blood mononuclear cells.
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Figure 4. Cytokine-mediated induction of CLEC7A (dectin-1) transcription
in cultured primary keratinocytes. Confluent cell cultures (N¼4–8) were
stimulated for 24 and 48 hours with IL-4 (50 ngml–1) and IL-13 (50 ngml–1);
IL-17 (30 ngml–1) and IL-22 (30 ngml–1); IFN-a (500Uml–1); or IFN-g
(500Uml–1). *P-value o0.05, **P-value o0.001.
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NLRP3 inflammasome is implicated in recognition of many
different stimuli, ranging from adenosine triphosphate and
RNA to uric acid, b-amyloid, asbestos, and even UV light
(Franchi et al., 2009; Kawai and Akira, 2009). The latter was
also reported in keratinocytes, although baseline NLRP3
expression levels were barely detectable (Feldmeyer et al.,
2007). Surprisingly, we found increased expression levels of
IL1RN, IL-1a, and IL-1b in AD. Reports regarding IL-1 in AD
are scarce, whereas more research has focused on IL-1 in
psoriasis. For example, overexpression of IL1RN was found in
psoriatic epidermis compared with normal epidermis (Debets
et al., 1997). In a clinical setting, treatment with the IL-1
receptor antagonist anakinra proved only hardy effective in
psoriasis (Gibbs et al., 2005), in contrast to the widely applied
tumor necrosis factor antagonists (Menter et al., 2008). Still,
the upregulation of IL1RN, IL-1a, and especially IL-1b in our
AD samples requires further investigation.
The highest upregulated PRR in psoriasis was dectin-1.
Although dectin-1 mRNA is also expressed by Langerhans
cells (M Teunissen, Amsterdam Medical Centre, personal
communication), we confirmed its increased protein expres-
sion levels on keratinocytes in psoriatic plaques with IHC and
immunofluorescence (Figure 2 and Supplementary Figure S1
online). Dectin-1 senses b-glucans, cell-wall components of
fungi such as Candida, Pneumocystis, and Aspergillus, and is
mainly expressed on monocytes, macrophages, and neutro-
phils, and in small amounts on dendritic cells, eosinophils, B,
and T cells (Willment et al., 2005). Dectin-1 signaling can
reinforce immune responses driven by TLR2, 4, 5, 7 and 9
(Gantner et al., 2003; Netea et al., 2006; Reid et al., 2009).
Dectin-1-deficient mice are more susceptible to Candida
albicans and Pneumocystis carinii infections (Saijo et al.,
2007; Taylor et al., 2007) and dectin-1 appeared to be crucial
in pulmonary defense against Aspergillus fumigatus (Werner
et al., 2009). In a human family, however, we found that
functional dectin-1 deficiency was associated with recurrent
vulvovaginal candidiasis and onychomycosis, but not
invasive fungal infections. Functional dectin-1 deficiency
did not impair fungal phagocytosis and fungal killing, which
underlined the specific function of dectin-1 in human
mucosal antifungal defense and the important role of other
Candida receptors in preventing invasion (Ferwerda et al.,
2009). Examples are MRC1 and TLR4 that recognize Candida
cell-wall-derived mannans and TLR2 that binds phospho-
lipomannan (Netea et al., 2006; Reid et al., 2009).
Previously, elevated IL-8 expression levels were found
after stimulation of keratinocytes with heat-killed Candida
albicans and this was shown to increase the Candida killing
activity by keratinocytes (Szolnoky et al., 2001; Pivarcsi
et al., 2003). As fungal colonization is absent in psoriatic
plaques, ligand-induced upregulation of dectin-1 is unlikely.
We deem it plausible that dectin-1 upregulation in psoriatic
plaques results from local lesional elevated IFN concentra-
tions and thus is coincidental. However, this upregulation
can result in improved immune responses against fungi that
happen to land on a plaque and are thus eliminated more
effectively.
Recently, the IL-23/Th17 pathway has become a focus of
attention in both psoriasis and Candida research (Di Cesare
et al., 2009; Nestle et al., 2009; van de Veerdonk et al.,
2009). Therefore, the increase in IL-23 mRNA we found in
keratinocytes after co-stimulation of dectin-1 and TLR5
seemed an interesting link between dectin-1 function and
psoriasis pathophysiology. IL-23 protein levels, however,
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Figure 5. Host response gene expression in cultured primary keratinocytes on stimulation with dectin-1, TLR2, and TLR5 ligands. After 24-hour preincubation
with IFN-g, confluent keratinocyte cultures (N¼4) were stimulated for 48 hours with b-glucan (50 mgml–1) or heat-killed (HK) Candida (5*106ml–1) with or
without addition of Pam3Cys-SKKKK (10 mgml–1) or flagellin (1 mgml–1). Gray versus white bars indicate the (synergistic) effect of dectin-1 stimulation and black
versus white bars the (synergistic) effect of concerted fungal receptor stimulation. (Supplementary Figure S2 online shows 24-hour stimulation data.) (a) Relative
quantity (RQ) of mRNA levels. (b) Protein levels of IL-6, IL-8, and hBD-2 in the supernatants are measured by ELISAs. It is to be noted that the data are presented
in a log10 scale. Bars indicate mean±SEM. *P-value o0.05.
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were below the detection level of our assay so this
association remains unclear. The ability of dectin-1 to trigger
immune responses is cell-type dependent. In dendritic cells,
e.g., dectin-1 signaling induces tumor necrosis factor
production directly, whereas this response requires additional
TLR co-stimulation in macrophages (LeibundGut-Landmann
et al., 2007; Dennehy et al., 2008). Such cell-specific
co-stimulation requirement might account for the limited
effects we found upon stimulation with dectin-1 ligands.
Therefore, keratinocytes might need concomitant signaling
through receptors other than TLR2 or TLR5 for proper dectin-
1 signaling. For TLR5 and TLR9 functioning, e.g., transforming
growth factor-a was identified as an important synergizing
factor in keratinocytes and a pathophysiological role in
psoriasis was suggested (Miller et al., 2005). Another possible
explanation is that optimal stimulation of dectin-1 requires
specific spatial cell wall distribution of b-glucans. Absence of
adapter proteins could also account for defective dectin-1
signaling, as was illustrated by a human recessive disorder
caused by a homozygous CARD9 mutation (Glocker et al.,
2009). We therefore tested CARD9, SYK, and RAF1 gene
expression in our in vivo and in vitro samples and found that
these genes are transcribed in normal epidermis and psoriatic
and AD lesions to a similar extent (Table 1). CARD9, SYK and
RAF1 were also transcribed in unstimulated primary human
keratinocytes in vitro. Moreover, none of the ligands (b-
glucan, heat-killed Candida, Pam3Cys, or flagellin) signi-
ficantly influenced the mRNA expression levels of these
genes. IFN-g, however, induced CARD9 significantly 5.8
times after 24 hours (not shown).
Finally, we examined whether selective expression of a
non-functional isoform of dectin-1 in keratinocytes could
explain our findings. The qPCR primers cover exon 1 and 2
that are present in all isoforms. The antibody we used for IHC
recognizes the full-length protein (isoform A) and the major
alternatively spliced isoform B that lacks the stalk region but
possesses the cytoplasmic, transmembrane, and extracellular
carbohydrate recognition domains, which determine function
(Willment et al., 2001). Previously, dectin-1 staining of
Langerhans cells, not keratinocytes, was reported in normal
skin and psoriatic lesions (Yokota et al., 2001). However, the
applied antibody was raised against a peptide from the stalk
region and by means of PCR we identified the stalk-lacking
isoform as the dominant dectin-1 isoform in keratinocytes
(Supplementary Figure S3 online). This affects antibody
specificity, but not functions, because both major isoforms
are functional.
In conclusion, many PRRs are expressed in normal human
epidermis, but only a few show significant differences in
expression levels between normal epidermis and psoriasis or
AD lesions. Dectin-1 is remarkably upregulated in psoriatic
lesions, but its function in the biology of skin inflammation
and infection remains to be further examined.
MATERIALS AND METHODS
Subjects
Four-millimeter punch biopsies were taken from chronic lesions of
moderate to severe plaque psoriasis (N¼ 15) and AD (N¼ 12).
Exclusion criteria were systemic or UVB-therapy or topical steroids
locally 2 weeks before the biopsy. Skin biopsies of healthy
volunteers (N¼ 11) served as control samples. In advance, approval
of the medical ethics committee region Arnhem-Nijmegen, and
individual written informed consent were obtained. The study was
conducted according to the Declaration of Helsinki principles. RNA
from different organs was available from autopsy material of one
individual (Department of Pathology, Radboud University Nijmegen
Medical Centre, Nijmegen, The Netherlands).
RNA isolation and quantitative real-time PCR
Purified epidermal sheets from healthy volunteers (N¼ 5), psoriasis
patients (N¼ 9), and AD patients (N¼ 6) were collected for mRNA
analysis and complementary DNA was generated and PCR-amplified
as previously described (de Jongh et al., 2005). Specific qPCR
primers were designed with Primer Express 1.0 Software (Applied
Biosystems, Carlsbad, CA), purchased from Biolegio (Nijmegen, The
Netherlands) and validated on skin, some on blood. Primers were
only accepted if their efficiency was 100 ±10% (Supplementary
Table S2 online). Using the comparative DDCt-method and RPLP0 as
reference gene, relative mRNA expression levels were calculated
(Livak and Schmittgen, 2001).
Immunohistochemistry
Full-thickness skin biopsies of healthy controls, psoriatic plaques,
and AD lesions were formalin-fixated and embedded in paraffin or
directly frozen and embedded in TissueTek (Sakura Finetek Europe,
Alphen aan den Rijn, The Netherlands) (N¼ 3 per condition).
Sections were processed for IHC staining with the avidin–biotin
complex method. The following primary antibodies were used, all
dissolved in 1% BSA: polyclonal goat antibody to melanoma
differentiation-associated gene-5 (Imgenex, San Diego, CA; IMG-
3202) (1:30), polyclonal goat antibody to ICEBERG (Santa Cruz,
Santa Cruz, CA; sc-14207) (1:10), monoclonal mouse antibody to
dectin-1 (R&D Systems, Minneapolis, MN; MAB 1859) (1:50), and
monoclonal mouse antibody to NLRP3 (Alexis, Lausen, Switzerland;
ALX-804-819-C100) (1:50). Dectin-1 staining was only possible on
frozen sections.
Cell culture
Primary human epidermal cells were isolated from the dermis
and cultured in keratinocyte growth medium (Zeeuwen et al., 2008).
At 100% confluency, the cells were stimulated with different
cytokine mixtures at concentrations that were optimized in previous
experiments: IL-4 50 ngml–1 with IL-13 50 ngml–1, IL-17 30 ngml–1
with IL-22 30 ngml–1, IL-1a 30 ngml–1 with tumor necrosis factor-a
30 ngml–1 and IL-6 2*104Uml–1, IFN-a 10–500Uml–1, IFN-g
10–500Uml–1 (PeproTech, Rocky Hill, NJ), or 5% fetal calf serum.
A dose-response study was performed with b-glucan 2–50 mgml–1
and heat-killed Candida albicans 0.2–5*106ml–1. In the final ligand-
stimulation study, cells were preincubated with IFN-g 500Uml–1 for
24 hours and stimulated with b-glucan 50 mgml–1 or heat-killed
Candida albicans 5*106ml–1 with or without addition of Pam3Cys-
SKKKK (EMC Microcollections, Tuebingen, Germany) 10 mgml–1 or
flagellin (Brunschwig Chemie, Amsterdam, The Netherlands)
1mgml–1. Cells and supernatants were harvested after 24 and
48 hours, and cells were stored in Trizol for RNA extraction. The
following ELISAs were performed on the supernatants: IL-1b
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(R&D, DY 201E), IL-6 (Sanquin, Amsterdam, The Netherlands;
M9316), IL-8 (Sanquin, M9318), IL-23 (eBioscience, San Diego, CA;
88-7237-88), and hBD-2 using a goat hBD-2 antibody (Abcam,
Cambridge, UK; ab9871) and a rabbit hBD-2 antiserum (Jansen
et al., 2009).
Statistics
For the qPCR experiments, statistical analysis by analysis of variance
was performed on DCt values corrected for primer efficiency,
followed by a Bonferroni (in vivo data) or least significant difference
(in vitro data) post hoc test using SPSS v16.0 (SPSS, Benelux BV,
Nieuwegein, The Netherlands). DCt is the difference between the
target gene and reference gene (RPLP0) Ct. It is to be noted that
relative expression levels are graphically shown (Figure 1) (Livak and
Schmittgen, 2001).
CONFLICT OF INTEREST
The authors state no conflict of interest.
ACKNOWLEDGMENTS
HDdK was supported by an AGIKO stipend from the Netherlands Organiza-
tion for Health Research and Development, MGN by a Vici grant from the
Netherlands Organization for Scientific Research, and PLJMZ by the Dutch
Ministry of Economic Affairs (PID082025). b-Glucan was kindly gifted by DL
Williams, Johnson City, Tennessee, DC complementary DNA by G Adema’s
group (Tumor Immunology Laboratory, NCMLS), and peripheral blood
mononuclear cell complementary DNA by M Stoffels. We thank F van de
Veerdonk for providing us with heat-killed Candida, L Jacobs and T Jansen for
performing cytokine ELISAs, and T Feuth for statistical advice.
SUPPLEMENTARY MATERIAL
Supplementary material is linked to the online version of the paper at http://
www.nature.com/jid
REFERENCES
Baker BS, Ovigne JM, Powles AV et al. (2003) Normal keratinocytes express
toll-like receptors (TLRs) 1, 2 and 5: modulation of TLR expression in
chronic plaque psoriasis. Br J Dermatol 148:670–9
Barton GM, Kagan JC (2009) A cell biological view of toll-like receptor
function: regulation through compartmentalization. Nat Rev Immunol
9:535–42
Begon E, Michel L, Flageul B et al. (2007) Expression, subcellular localization
and cytokinic modulation of toll-like receptors (TLRs) in normal human
keratinocytes: TLR2 up-regulation in psoriatic skin. Eur J Dermatol 17:
497–506
Berland R, Fernandez L, Kari E et al. (2006) Toll-like receptor 7-dependent
loss of B cell tolerance in pathogenic autoantibody knockin mice.
Immunity 25:429–40
Cavassani KA, Ishii M, Wen H et al. (2008) TLR3 is an endogenous sensor of
tissue necrosis during acute inflammatory events. J Exp Med 205:
2609–21
Christensen SR, Shlomchik MJ (2007) Regulation of lupus-related autoanti-
body production and clinical disease by toll-like receptors. Semin
Immunol 19:11–23
de Jongh GJ, Zeeuwen PL, Kucharekova M et al. (2005) High expression levels
of keratinocyte antimicrobial proteins in psoriasis compared with atopic
dermatitis. J Invest Dermatol 125:1163–73
Debets R, Hegmans JP, Croughs P et al. (1997) The IL-1 system in psoriatic
skin: IL-1 antagonist sphere of influence in lesional psoriatic epidermis.
J Immunol 158:2955–63
Dennehy KM, Ferwerda G, Faro-Trindade I et al. (2008) Syk kinase is required
for collaborative cytokine production induced through dectin-1 and toll-
like receptors. Eur J Immunol 38:500–6
Di Cesare A, Di MP, Nestle FO (2009) The IL-23/Th17 axis in the
immunopathogenesis of psoriasis. J Invest Dermatol 129:1339–50
Feldmeyer L, Keller M, Niklaus G et al. (2007) The inflammasome mediates
UVB-induced activation and secretion of interleukin-1beta by keratino-
cytes. Curr Biol 17:1140–5
Ferwerda B, Ferwerda G, Plantinga TS et al. (2009) Human dectin-1
deficiency and mucocutaneous fungal infections. N Engl J Med
361:1760–7
Franchi L, Warner N, Viani K et al. (2009) Function of NOD-like
receptors in microbial recognition and host defense. Immunol Rev
227:106–28
Gantner BN, Simmons RM, Canavera SJ et al. (2003) Collaborative induction
of inflammatory responses by dectin-1 and toll-like receptor 2. J Exp Med
197:1107–17
Gibbs A, Markham T, Walsh C et al. (2005) Anakinra (Kineret) in psoriasis and
psoriatic arthritis: a single-center, open-label, pilot study. Arthritis Res
Therapy 7(Suppl 1):P68
Glocker EO, Hennigs A, Nabavi M et al. (2009) A homozygous CARD9
mutation in a family with susceptibility to fungal infections. N Engl J Med
361:1727–35
Harder J, Dressel S, Wittersheim M et al. (2010) Enhanced expression
and secretion of antimicrobial peptides in atopic dermatitis and after
superficial skin injury. J Invest Dermatol 130:1355–64
Harder J, Nunez G (2009) Functional expression of the intracellular pattern
recognition receptor NOD1 in human keratinocytes. J Invest Dermatol
129:1299–302
Hayashi F, Smith KD, Ozinsky A et al. (2001) The innate immune response
to bacterial flagellin is mediated by toll-like receptor 5. Nature
410:1099–103
Howell MD (2007) The role of human beta defensins and cathelicidins in
atopic dermatitis. Curr Opin Allergy Clin Immunol 7:413–7
Jansen PA, Rodijk-Olthuis D, Hollox EJ et al. (2009) Beta-defensin-2 protein
is a serum biomarker for disease activity in psoriasis and reaches
biologically relevant concentrations in lesional skin. PLoS One
4:e4725
Kalali BN, Kollisch G, Mages J et al. (2008) Double-stranded RNA induces
an antiviral defense status in epidermal keratinocytes through TLR3-,
PKR-, and MDA5/RIG-I-mediated differential signaling. J Immunol 181:
2694–704
Kamsteeg M, Jansen PA, Van Vlijmen-Willems IM et al. (2009) Molecular
diagnostics of psoriasis, atopic dermatitis, allergic contact dermatitis and
irritant contact dermatitis. Br J Dermatol 162:568–78
Kariko K, Ni H, Capodici J et al. (2004) mRNA is an endogenous ligand for
toll-like receptor 3. J Biol Chem 279:12542–50
Kawai K, Shimura H, Minagawa M et al. (2002) Expression of functional
toll-like receptor 2 on human epidermal keratinocytes. J Dermatol Sci
30:185–94
Kawai T, Akira S (2009) The roles of TLRs, RLRs and NLRs in pathogen
recognition. Int Immunol 21:317–37
Kikkert R, Bulder I, de Groot ER et al. (2007) Potentiation of toll-like receptor-
induced cytokine production by (1–43)-beta-D-glucans: implications
for the monocyte activation test. J Endotoxin Res 13:140–9
Kobayashi M, Yoshiki R, Sakabe J et al. (2009) Expression of toll-like
receptor 2, NOD2 and dectin-1 and stimulatory effects of their ligands
and histamine in normal human keratinocytes. Br J Dermatol 160:
297–304
Kollisch G, Kalali BN, Voelcker V et al. (2005) Various members of the
toll-like receptor family contribute to the innate immune response of
human epidermal keratinocytes. Immunology 114:531–41
Kummer JA, Broekhuizen R, Everett H et al. (2007) Inflammasome
components NALP 1 and 3 show distinct but separate expression
profiles in human tissues suggesting a site-specific role in the
inflammatory response. J Histochem Cytochem 55:443–52
Lai Y, Di Nardo A, Nakatsuji T et al. (2009) Commensal bacteria regulate
toll-like receptor 3-dependent inflammation after skin injury. Nat Med
15:1377–82
www.jidonline.org 2619
HD de Koning et al.
PRR Expression in Human Epidermis
Lebre MC, van der Aar AM, van Baarsen L et al. (2007) Human keratinocytes
express functional toll-like receptor 3, 4, 5, and 9. J Invest Dermatol
127:331–41
Lee HM, Shin DM, Choi DK et al. (2009) Innate immune responses to
mycobacterium ulcerans via toll-like receptors and dectin-1 in human
keratinocytes. Cell Microbiol 11:678–92
LeibundGut-Landmann S, Gross O, Robinson MJ et al. (2007) Syk- and
CARD9-dependent coupling of innate immunity to the induction of
T helper cells that produce interleukin 17. Nat Immunol 8:630–8
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using
real-time quantitative PCR and the 2(-Delta Delta C(T)) method.Methods
25:402–8
Mempel M, Voelcker V, Kollisch G et al. (2003) Toll-like receptor expression
in human keratinocytes: nuclear factor kappaB controlled gene activa-
tion by Staphylococcus aureus is toll-like receptor 2 but not toll-like
receptor 4 or platelet activating factor receptor dependent. J Invest
Dermatol 121:1389–96
Menter A, Gottlieb A, Feldman SR et al. (2008) Guidelines of care for the
management of psoriasis and psoriatic arthritis: section 1. Overview of
psoriasis and guidelines of care for the treatment of psoriasis with
biologics. J Am Acad Dermatol 58:826–50
Miller LS, Modlin RL (2007) Human keratinocyte toll-like receptors promote
distinct immune responses. J Invest Dermatol 127:262–3
Miller LS, Sorensen OE, Liu PT et al. (2005) TGF-alpha regulates TLR
expression and function on epidermal keratinocytes. J Immunol
174:6137–43
Mogensen TH (2009) Pathogen recognition and inflammatory signaling in
innate immune defenses. Clin Microbiol Rev 22:240–73
Nestle FO, Kaplan DH, Barker J (2009) Psoriasis. N Engl J Med 361:496–509
Netea MG, Gow NA, Munro CA et al. (2006) Immune sensing of Candida
albicans requires cooperative recognition of mannans and glucans by
lectin and toll-like receptors. J Clin Invest 116:1642–50
Neven B, Prieur AM, Quartier dit Maire P (2008) Cryopyrinopathies: update
on pathogenesis and treatment. Nat Clin Pract Rheumatol 4:481–9
Nomura I, Gao B, Boguniewicz M et al. (2003a) Distinct patterns of gene
expression in the skin lesions of atopic dermatitis and psoriasis: a gene
microarray analysis. J Allergy Clin Immunol 112:1195–202
Nomura I, Goleva E, Howell MD et al. (2003b) Cytokine milieu of atopic
dermatitis, as compared to psoriasis, skin prevents induction of innate
immune response genes. J Immunol 171:3262–9
Ong PY, Ohtake T, Brandt C et al. (2002) Endogenous antimicrobial peptides
and skin infections in atopic dermatitis. N Engl J Med 347:1151–60
Palm NW, Medzhitov R (2009) Pattern recognition receptors and control
of adaptive immunity. Immunol Rev 227:221–33
Pivarcsi A, Bodai L, Rethi B et al. (2003) Expression and function of toll-like
receptors 2 and 4 in human keratinocytes. Int Immunol 15:721–30
Prens EP, Kant M, van Dijk G et al. (2008) IFN-alpha enhances poly-IC
responses in human keratinocytes by inducing expression of cytosolic
innate RNA receptors: relevance for psoriasis. J Invest Dermatol
128:932–8
Reid DM, Gow NA, Brown GD (2009) Pattern recognition: recent insights
from Dectin-1. Curr Opin Immunol 21:30–7
Saijo S, Fujikado N, Furuta T et al. (2007) Dectin-1 is required for host
defense against Pneumocystis carinii but not against Candida albicans.
Nat Immunol 8:39–46
Song PI, Park YM, Abraham T et al. (2002) Human keratinocytes express
functional CD14 and toll-like receptor 4. J Invest Dermatol 119:424–32
Szolnoky G, Bata-Csorgo Z, Kenderessy AS et al. (2001) A mannose-binding
receptor is expressed on human keratinocytes and mediates killing of
Candida albicans. J Invest Dermatol 117:205–13
Taylor PR, Tsoni SV, Willment JA et al. (2007) Dectin-1 is required for
beta-glucan recognition and control of fungal infection. Nat Immunol
8:31–8
van de Veerdonk F, Marijnissen RJ, Kullberg BJ et al. (2009) The macrophage
mannose receptor induces IL-17 in response to Candida albicans. Cell
Host Microbe 5:329–40
van Ruissen F, de Jongh GJ, Zeeuwen PL et al. (1996) Induction of normal and
psoriatic phenotypes in submerged keratinocyte cultures. J Cell Physiol
168:442–52
Werner JL, Metz AE, Horn D et al. (2009) Requisite role for the dectin-1 beta-
glucan receptor in pulmonary defense against Aspergillus fumigatus.
J Immunol 182:4938–46
Willment JA, Gordon S, Brown GD (2001) Characterization of the human
beta-glucan receptor and its alternatively spliced isoforms. J Biol Chem
276:43818–23
Willment JA, Marshall AS, Reid DM et al. (2005) The human beta-glucan
receptor is widely expressed and functionally equivalent to murine
dectin-1 on primary cells. Eur J Immunol 35:1539–47
Yokota K, Takashima A, Bergstresser PR et al. (2001) Identification of a human
homologue of the dendritic cell-associated C-type lectin-1, dectin-1.
Gene 272:51–60
Zeeuwen PL, de Jongh GJ, Rodijk-Olthuis D et al. (2008) Genetically
programmed differences in epidermal host defense between psoriasis
and atopic dermatitis patients. PLoS One 3:e2301
2620 Journal of Investigative Dermatology (2010), Volume 130
HD de Koning et al.
PRR Expression in Human Epidermis
